Whalen Kathleen M's Form 4 filing
HCA Healthcare, Inc. (HCA) · filed Jul 31, 2024
- Accession no.
- 0000950170-24-088748
- Filed
- Jul 31, 2024
- Trade date
- Jul 29-31, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.76M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Whalen Kathleen MCIK 0001763910 | Officer (SVP & Chief Ethics Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2024 | Common Stock | MOption exerciseAcquired | +8,280 | $145.24 | +$1,202,587.2 | 19,598 | Direct | |
| Jul 29, 2024 | Common Stock | FTax withholdingDisposed | −5,293 | $358.73 | −$1,898,757.89 | 14,305 | Direct | |
| Jul 29, 2024 | Common Stock | SSaleDisposed | −1,864 | $359.92 | −$670,890.88 | 12,441 | Direct | |
| Jul 31, 2024 | Common Stock | SSaleDisposed | −2,987 | $363.51 | −$1,085,804.37 | 9,454 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2024 | Common Stock | MOption exerciseDisposed | −8,280 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.